Search Results
Feb 04, 2026, 10:15 ET Bain & Company appoints Jamie Cleghorn to lead its global Customer practice
François Faelli, Global Head of Capabilities at Bain & Company. "Jamie brings a rare combination of strategic rigor, commercial instinct, and technological fluency. He is exceptionally well positioned to build on the practice's strong
More news about: Bain & Company
Feb 04, 2026, 10:00 ET Savor Launches Personal Care & Beauty Division, Bringing Carbon-Based Platform to Cosmetics Industry
luxurious feel and conditioning benefits traditionally sourced from animals in a pure, consistent and radically responsible form. Mimetic features rare, skin-mimicking lipids (molecules that echo the skin's own barrier structure and are abundant in Savor's platform yet scarce in plant oils) to help restore
More news about: Savor
Feb 04, 2026, 09:05 ET Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its novel oral therapy targeting
More news about: Cumberland Pharmaceuticals Inc.
Feb 04, 2026, 09:00 ET Mezzion Pharmaceuticals Applauds Give Kids a Chance Act Becoming Law
restores the Rare Pediatric Disease Priority Review Voucher (PRV) program and advances reforms designed to support pediatric drug development and accelerate patient access to life-saving therapies."This signing reinforces a national commitment to children and families living with rare diseases,"
More news about: Mezzion Pharmaceuticals, Inc
Feb 04, 2026, 09:00 ET King of Kentucky introduces Small Batch Collection honoring the 250th Anniversary of the United States
the brand since 1936 and revived it in 2018. It has become one of the most sought-after bottles in whiskey."For years, I've held onto these rare, aged barrels, waiting for a moment significant enough to share them," said Chris Morris, Brown-Forman Master Distiller Emeritus. "To celebrate the founding
More news about: King of Kentucky
Feb 04, 2026, 09:00 ET DESERT MOUNTAIN ENERGY APPOINTS TIMOTHY S. ORR, Esq. AS COO, ADVANCES "PROJECT HELIOS." THE FUTURE OF AI POWER & DEFENCE INFRASTRUCTURE
Department of Defense (DOW) symposium in Phoenix, AZ, management engaged with NATO, the UK MoD, and the US DoE. Discussions focused on the secure supply of rare gases and energy for industry titans, including Lockheed Martin, RTX, Gore, and Seekr (Mission First AI).ABOUT DESERT MOUNTAIN ENERGY Desert
More news about: Desert Mountain Energy Corp.
Feb 04, 2026, 08:55 ET Central Holidays Unveils a New Dimension of Experiential Travel with Its Exclusive 2027 Egypt Solar Eclipse Journey and Announces Expanded Role of Egypt Expert Mayye Osman to Further Support Travel Advisors
Total Solar Eclipse viewing experience, complete with expert commentary and professionally arranged observation settings to ensure guests witness this rare cosmic event in comfort and style. The program also includes round-trip domestic flights from Cairo to Aswan and the option to add a once-in-a-lifetime
More news about: Central Holidays
Feb 04, 2026, 08:54 ET Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
leadership roles include serving as CEO of Microchips Biotech and as Senior Vice President & Chief Scientific Officer of Zimmer."Cheryl brings a rare combination of scientific depth, operational rigor, commercial leadership, and board experience—paired with a proven track record of transforming organizations
More news about: Lumicell, Inc.
Feb 04, 2026, 08:30 ET From FIH to POC -- Designing Phase I/Ib Trials with Efficiency, Upcoming Webinar Hosted by Xtalks
experience, supported by deep therapeutic expertise in complex indications such as endocrinology and metabolism, inflammatory diseases, neuroscience and rare diseases.TORONTO, Feb. 4, 2026 /PRNewswire/ -- The future of drug
More news about: Xtalks
Feb 04, 2026, 08:28 ET There Was Gold in Them-Thar Lots at Morphy's Jan. 23 Old West & Native American Art Auction in Las Vegas, Which Surpassed $1.5M
surfaces and excellent luster. The name of the mining company was signified by a five-point star above the letters "MINING CO." These bars are extremely rare, and this example changed hands for $44,280.The only non-gold item to crack the top four lots was a circa-1902 framed poster for "Buffalo Bill's
More news about: Morphy Auctions
Feb 04, 2026, 08:08 ET Aminex Therapeutics Announces Multiple Sites Activated for Phase 1b/2 Clinical Trial of Novel Investigational Cancer Treatment AMXT 1501 and DFMO in Patients with Breast Cancer or Melanoma
Aminex Therapeutics, Inc., a private clinical-stage biotechnology company focused on developing novel therapies for rare and difficult-to-treat cancers, today announced the initiation of a Phase 1b/2 clinical trial of AMXT 1501 in combination with difluoromethylornithine
More news about: Aminex Therapeutics, Inc.
Feb 04, 2026, 08:00 ET Mercy BioAnalytics Appoints Darrin Crisitello as Chief Commercial Officer
led successful launches of diagnostic products spanning women's health, oncology, and neurology."Darrin is a proven commercial leader with a rare combination of strategic vision and hands-on execution," said Dawn Mattoon, Chief Executive Officer of Mercy. "His experience commercializing breakthrough
More news about: Mercy BioAnalytics
Feb 04, 2026, 08:00 ET Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
to make a personalized vaccine for him. Adam was the first person to receive a Providence cancer vaccine, and he responded remarkably well. It is a rare good-news story, and he is still doing well today. Providence's mission today is to see Adam's success shared as widely as possible.""This
More news about: Providence Therapeutics Holdings Inc
Feb 04, 2026, 06:00 ET Providence Medical Technology Appoints Industry Veteran Jim Hens as Chief Commercial Officer as the Company Continues Rapid Growth Following Publication of Landmark Study
inflection point where Providence's clinical evidence is accelerating market demand," said Scott Lynch, Chief Product Officer for Providence. "Jim is a rare talent who combines deep operational expertise and spine industry knowledge with a visionary approach to sales leadership. His skill in successfully
More news about: Providence Medical Technology, Inc.
Feb 04, 2026, 06:00 ET Stanley Black & Decker Reports 4Q and Full Year 2025 Results
and rare earth related controls and other monetary and non-monetary trade regulations or barriers; (iv) the Company's ability to predict the timing and extent of any trade related regulations, clearances, restrictions, including but not limited to, trade barriers, tariffs, raw material and rare earth
More news about: Stanley Black & Decker, Inc.
Feb 04, 2026, 05:02 ET Foresee Pharmaceuticals Receives the Fourth Positive Recommendation from the DSMB to Continue the Casppian Ph3 Study, for Central Precocious Puberty (CPP)
with derived drug products targeting specialty markets and secondly, its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs.Foresee's product portfolio includes late and early-stage programs. CAMCEVI 42 mg, for the treatment
More news about: Foresee Pharmaceuticals Co., Ltd.
Feb 04, 2026, 04:38 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
-- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that it is broadening the development focus of its HDAC inhibitor CS014 to pulmonary hypertension
More news about: Cereno Scientific
Feb 04, 2026, 04:29 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
-- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that it is broadening the development focus of its HDAC inhibitor CS014 to pulmonary hypertension
More news about: Cereno Scientific
Feb 04, 2026, 03:00 ET Performance Brokerage Services Advises on the Sale of Kroubetz Lakeside Campers in Lake Crystal, Minnesota to Bretz RV & Marine
Award.Brandon Bretz, President of Bretz RV & Marine, commented, "Jesse Stopnitzky was exceptional to work with throughout the process. He demonstrated a rare ability to balance professionalism, incredible patience, and persistence through a challenging transaction. Jesse was constantly available and deeply
More news about: Performance Brokerage Services, Inc.
Feb 03, 2026, 21:26 ET /C O R R E C T I O N -- Carrberry Companies/
introduction of Recording Academy President Harvey Mason Jr. —a rare editorial decision signaling the song's renewed relevance as both cultural touchstone and living statement.In a week dominated by spectacle, Art Garfunkel offered something rare: a performance with a history of courage and reprised in
More news about: Carrberry Companies
Feb 03, 2026, 18:45 ET Pacaso Introduces Infinity, an Invitation-Only Home Exchange for the World's Most Extraordinary Homes
Infinity is designed for a rare kind of homeowner: an owner of a remarkable, $5M–$20M residence in a coveted destination who understands the care, intention, and trust such a home
More news about: Pacaso
Feb 03, 2026, 17:55 ET METC Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Ramaco Resources, Inc.
Resources, Inc. (NASDAQ: METC) securities between July 31, 2025 and October 23, 2025. Ramaco engages in the mining, development, and sale of coal and rare earth minerals.
More news about: Robbins LLP
Feb 03, 2026, 17:45 ET Federal Law Brings Hope to Individuals and Families Living with SMA, Expands Access and Research
funding opportunities for researchers nationwide.Extension of Rare Disease Innovation Program – The FDA's Rare Pediatric Disease Priority Review Voucher Program is extended, supporting continued investment in rare disease therapies, including SMA.Improved Access to Specialized
More news about: Cure SMA
Feb 03, 2026, 16:01 ET AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
price. For 2026, we expect accelerated sales erosion driven by increased competition, as multiple biosimilars have launched globally.Rare DiseaseTEPEZZA® (teprotumumab-trbw) sales decreased 1% year-over-year to $457 million in the fourth
More news about: Amgen
Feb 03, 2026, 15:45 ET Transit Technologies Appoints Srithal Bellary as Chief Technology, Data & AI Officer to Lead AI-First Platform Transformation
busHive, into an intelligent, connected platform that enables safer, more efficient, and more personalized transit experiences."Srithal brings a rare combination of deep technical expertise, platform-scale vision, and AI-first leadership," said
More news about: Transit Technologies